NCT03875820 2026-03-10FRAMEInstitute of Cancer Research, United KingdomPhase 1 Active not recruiting87 enrolled
NCT04498520 2021-05-18Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerUniversity of California, San FranciscoPhase 1 Withdrawn